Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company focused on developing and commercializing biosimilars, which are biologic drugs that closely resemble existing biologic medications. Established in 2012 as a joint venture between Samsung Biologics and Biogen, the company became a wholly owned subsidiary of Samsung Biologics in 2022. Its mission is to...